cancer clinical trials for Thoracic (ONC)

16 Thoracic (ONC) clinical trials found. View a list of all cancer clinical trial types.

• Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

  Current Status: Open

  View links and contact information related to this clinical trial

• Phase I/II study to assess the safety and efficacy of consolidative hypofractionated radiation therapy (hfRT) for boosting the residual primary lung cancer in combination with Durvalumab after definitive chemoradiation therapy for stage III non-small cell lung cancer (NSCLC)

  Current Status: Open

  View links and contact information related to this clinical trial

• Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO

  Current Status: Open

  View links and contact information related to this clinical trial

• Ivonescimab Combined with Chemotherapy Versus Pembrolizumab Combined with Chemotherapy for the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer

  Current Status: Open

  View links and contact information related to this clinical trial

• A randomized phase II trial of adjuvant Pembrolizumab versus observation following curative resection for stage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 cm: Big Ten Cancer Research Consortium BTCRC-LUN18-153

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation

  Current Status: Open

  View links and contact information related to this clinical trial

• A PHASE 1 DOSE ESCALATION AND EXPANDED COHORT STUDY OF P-MUC1C-ALLO1 IN ADULT SUBJECTS WITH ADVANCED OR METASTATIC SOLID TUMORS

  Current Status: Open

  View links and contact information related to this clinical trial

• A Study of Sigvotatug Vedotin Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer (Be6A Lung-01).

  Current Status: Open

  View links and contact information related to this clinical trial

• Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST) (A151216)

  Current Status: Open

  View links and contact information related to this clinical trial

• Targeted Agent and Profiling Utilization Registry (TAPUR) Study

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized, Open-label Study of Serplulimab Plus Chemotherapy (Carboplatin-Etoposide) in Comparison With Atezolizumab Plus Chemotherapy in Previously Untreated US Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) (ASTRIDE)

  Current Status: Open

  View links and contact information related to this clinical trial

• A PHASE 1, FIRST IN HUMAN STUDY OF TORL-4-500 IN PATIENTS WITH ADVANCED CANCER

  Current Status: Not Open

  View links and contact information related to this clinical trial

• ESTABLISHMENT OF A NATIONAL BIOREPOSITORY TO ADVANCE STUDIES OF IMMUNE-RELATED ADVERSE EVENTS

  Current Status: Open

  View links and contact information related to this clinical trial

• Evaluating the PD-1 checkpoint inhibitor, Cemiplimab, as neoadjuvant therapy in high risk localized, locally recurrent and regionally advanced cutaneous squamous cell carcinoma: a Phase II pilot study (NeoPOWER)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized Study Evaluating GLIADEL Compared to Stereotactic Radiosurgery in Patients with Metastatic Brain Disease

  Current Status: Open

  View links and contact information related to this clinical trial

• A phase 2 study of brentuximab vedotin in combination with pembrolizumab in subjects with metastatic solid malignancies

  Current Status: Open

  View links and contact information related to this clinical trial